Prenatal Intravenous Magnesium and Neurodevelopmental Outcomes in Offspring

JAMA. 2023 Dec 19;330(23):2306-2307. doi: 10.1001/jama.2023.21723.

Authors

Stéphane Marret¹, Clément Chollat², Loïc Sentilhes³

Affiliations

¹ Department of Neonatology and Intensive Care-Neuropediatrics, Rouen University Hospital-Charles-Nicolle, Rouen, France.
² Department of Neonatal Pediatrics, Trousseau University Hospital, Paris, France.
³ Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France.

PMID: 38112818
DOI: 10.1001/jama.2023.21723

No abstract available

Publication types

Comment

MeSH terms

Administration, Intravenous
Female
Humans
Infant Death* / prevention & control
Magnesium* / administration & dosage
Magnesium* / therapeutic use
Neurodevelopmental Disorders* / etiology
Neurodevelopmental Disorders* / mortality
Neurodevelopmental Disorders* / prevention & control
Neuroprotective Agents* / administration & dosage
Neuroprotective Agents* / therapeutic use
Perinatal Death / prevention & control
Pregnancy
Vitamins

Substances

Magnesium
Neuroprotective Agents
Vitamins